Discussion
- one of the first bisphosphonates used to treat patients with cancer-related hypercalcemia;
- it can be administered either as an intravenous infusion in a dose of 4-6 mg per km given over a period of two to five hours qd for 3-5 days or as single IV infusion given over 2-9 hr period